SUPN

Neutral

Charles Schwab Investment Management Inc. Has $34.97 Million Stock Position in Supernus Pharmaceuticals, Inc. $SUPN

Charles Schwab Investment Management Inc. lowered its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 3.9% during the fourth qu...

thelincolnianonline 2 weeks ago 0

Bullish

Supernus Pharmaceuticals Q1 2026 Financial Results and Analyst Call Highlights - News and Statistics

Supernus Pharmaceuticals reported strong Q1 2026 results, exceeding revenue and adjusted EBITDA estimates, driven by robust demand for key products li...

IndexBox 2 weeks ago 0